Table 2.

Percent of Patients not Receiving Bone Mineral Density Testing Within Selected Time Periods After Starting Aromatase Inhibitors

	% of patients who did not receive BMD testing
Sample	0–14 months	14.1–26 months	26.1–38 months
Remained on AI ≥9 months with no indication of osteoporosis in 1 year before starting AI (n=342)	56	NAa	NAa
Remained on AI ≥23 months with no indication of osteoporosis 1 year before through 14 months after AI start (n=251)	56	75	NAa
Remained on AI ≥35 months with no indication of osteoporosis 1 year before through 26 months after AI start (n=174)	52	77	66

^aNA, not applicable.